当前位置:
						首页 
					
				>
						产品中心 >
						clinical_research >
						绝对抗体/Ab00740-10.0抗DR5[PRO95780(Drozitumab)]/Ab00740-10.0/200µg
					
								绝对抗体/Ab00740-10.0抗DR5[PRO95780(Drozitumab)]/Ab00740-10.0/200µg
								
										商品编号:
										Ab00740-10.0
									
									
										品牌:
										absoluteantibody
									
									
								
										市场价:
										¥5400.00
									
									
										美元价:
										3240.00
									
								
										产品分类:
										临床研究
									
									
										公司分类:
										clinical_research
									
								
										联系Q Q:
										3392242852
									
									
										电话号码:
										4000-520-616
									
								
										电子邮箱:
										info@ebiomall.com
									
									商品介绍
						Description: Recombinant monoclonal antibody to DR5. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the therapeutic antibody PRO95780 (Drozitumab). 
Species and Isotype: Human IgG1, lambda
Clone Number: PRO95780 (Drozitumab)
UniProt Accession Number of Target Protein: O14763
Published Application(s): functional/therapeutic; agonist; IP; immunoblot; ELISA; IF
Published Species Reactivity: Human
Immunogen: The variable domains of this antibody were derived as scFv from a human antibody phage display library, with biotinylated DR5-Fc used to capture DR5-specific phage. The scFv obtained were subsequently reformatted into full-length antibodies.
Specificity: This antibody is specific for human death receptor 5, a proapoptotic receptor widely expressed in adult and fetal tissues, with notably high expression on tumour cells. Activation of DR5 triggers apoptosis in various types of cancer cells, without affecting most normal cell types.
Application Notes: This antibody binds DR5, triggering DR5 clustering and DISC activation in a range of cancer cells, including colorectal cancer and NSCLC cells (Adams, 2009). Conversely, this antibody showed no effector caspase activation or cell death induction in normal human hepatocytes. In vivo, this antibody has been shown to inhibit tumor xenograft growth in a variety of animal models (Varfolomeev, 2009). This antibody was used in IP, immunoblot, ELISA and IF analysis to precisely characterise its interaction with the DR5 ligand (Adams, 2009).
Antibody First Published in:
Adams et al. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death Differ. 2008 Apr;15(4):751-61 PMID:18219321 Note on publication: Describes the generation of this antibody from a phage display library, and subsequent characterisation of its binding specificity.
Concentration: See vial label.
 
Important note – This product is for research use only. It is not intended for use in therapeutic or diagnostic
procedures for humans or animals.Species and Isotype: Human IgG1, lambda
Clone Number: PRO95780 (Drozitumab)
UniProt Accession Number of Target Protein: O14763
Published Application(s): functional/therapeutic; agonist; IP; immunoblot; ELISA; IF
Published Species Reactivity: Human
Immunogen: The variable domains of this antibody were derived as scFv from a human antibody phage display library, with biotinylated DR5-Fc used to capture DR5-specific phage. The scFv obtained were subsequently reformatted into full-length antibodies.
Specificity: This antibody is specific for human death receptor 5, a proapoptotic receptor widely expressed in adult and fetal tissues, with notably high expression on tumour cells. Activation of DR5 triggers apoptosis in various types of cancer cells, without affecting most normal cell types.
Application Notes: This antibody binds DR5, triggering DR5 clustering and DISC activation in a range of cancer cells, including colorectal cancer and NSCLC cells (Adams, 2009). Conversely, this antibody showed no effector caspase activation or cell death induction in normal human hepatocytes. In vivo, this antibody has been shown to inhibit tumor xenograft growth in a variety of animal models (Varfolomeev, 2009). This antibody was used in IP, immunoblot, ELISA and IF analysis to precisely characterise its interaction with the DR5 ligand (Adams, 2009).
Antibody First Published in:
Adams et al. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death Differ. 2008 Apr;15(4):751-61 PMID:18219321 Note on publication: Describes the generation of this antibody from a phage display library, and subsequent characterisation of its binding specificity.
Product Form
Purification: Protein A affinity purified Supplied in: PBS only.
 Storage Recommendation: Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°CConcentration: See vial label.
品牌介绍
						Absolute antibody本公司服务于抗体测序、制造和工程服务提供给所有抗体使用者和不断增长的抗体。Absolute Antibody Ltd was founded in Oxford, UK, in August 2012, with the vision that all antibody users should be able to use recombinant antibodies, which are absolutely defined by their amino acid sequence. This view gained support in 2015 with a Comment in Nature magazine by Bradbury and Pluckthun (+110 co-signatories) – “Reproducibility: Standardize antibodies used in research“. Rather than creating entirely new antibodies (or antibody-like molecules), we are building a catalog by taking existing antibodies (often from hybridomas) then manufacturing them in a superior way and improving their usefulness by engineering.品牌货号名称规格absoluteantibody21 E11Anti-Api m 21 kitabsoluteantibodyBAB2Anti-Bet v 1 1 kitabsoluteantibodyBAB3Anti-Bet v 11 kitabsoluteantibodyBAB4Anti-Bet v 11 kitabsoluteantibodyBAB5Anti-Bet v 1 1 kitabsoluteantibodyBV16Anti-Bet v 1 1 kitabsoluteantibodyM0418Anti-Bet v 11 kitabsoluteantibody4C3Anti-Bla g 2 1 kitabsoluteantibody7C11Anti-Bla g 21 kitabsoluteantibodyD1Anti-Bos d 5 1 kitabsoluteantibody6A8Anti-Der f 11 kitabsoluteantibody10B9Anti-Der p 11 kitabsoluteantibody5H8Anti-Der p 11 kitabsoluteantibody4C1Anti-Neurotoxin AahII1 kitabsoluteantibodyH10Anti-Der p 21 kit
					品牌分类
				关注表位标记
								Primary Antibodies
								Recombinant Antibodies from Human Patients
								Anti-Allergen Antibodies
								多标签控制蛋白
								Recombinant Isotype Controls
								抗过敏原抗体
								重组F4/80克隆CI:A3-1
								体内研究用重组抗体
									
			
联络我们
	服务热线:4000-520-616
		(限工作日9:00-18:00)
		 QQ :1570468124
		手机:18915418616
		
	
		